Gene | WT | eIL-1R1kd | ||
---|---|---|---|---|
CON | RSD | CON | RSD | |
IL-1β | 1.02 ± 0.09 | 4.37 ± 1.08*,‡ | 1.28 ± 0.36 | 2.19 ± 0.37* |
TNF-α | 1.03 ± 0.11 | 3.19 ± 1.04* | 1.24 ± 0.37 | 1.21 ± 0.32 |
IL-6 | 1.19 ± 0.31 | 4.01 ± 1.88*,‡ | 1.86 ± 0.64 | 1.27 ± 0.22 |
CCL2 | 1.03 ± 0.09 | 11.30 ± 4.93*,‡ | 1.57 ± 0.40 | 2.59 ± 0.74 |
CD14 | 1.03 ± 0.11 | 4.18 ± 1.80* | 1.10 ± 0.31 | 2.08 ± 0.47 |
CX3CR1 | 1.00 ± 0.03 | 0.74 ± 0.10# | 1.09 ± 0.21 | 0.72 ± 0.11# |
WT and eIL-1R1kd FVB mice were subjected to RSD or left undisturbed as CON mice. Enriched brain CD11b+ cells were collected, and relative mRNA expression of IL-1β, TNF-α, IL-6, CCL2, CD14, and CX3CR1 is shown. Values represent average ± SEM.
↵*p < 0.05, significantly different from WT–CON;
↵#p < 0.10, different from WT–CON;
↵‡p < 0.05, significantly different from eIL-1R1kd–CON.